Influence of Chemotherapy on Postural Control in Women With Cancer

Cancer, Breast Clinical Trial

Official title: Influence of Chemotherapy on Postural Control and Quality of Life in Women With Gynaecological Cancer: a Prospective Observational Study

Status Completed

Clinical Trial Summary

The aim of this study is to understand the strategies for adapting postural control in patients who have received chemotherapy treatment for gynaecological cancer.

Clinical Trial Description

Chemotherapy can cause many side effects, including peripheral neuropathies. Chemotherapy induced peripheral neuropathies (CIPN) are primarily sensory impairments that can alter the signals for somatosensory feedback and thus affect the postural control in the standing position. The objective of this study is to evaluate the impact of chemotherapy and peripheral neuropathies on postural control in the standing position. As balance maintenance is a complex construct involving different systems, this study will evaluate maintenance strategies during sensory disturbances in order to better understand post-chemotherapy coping strategies. These sensory disturbances concern vision (eyes closed) and the alteration of the somatosensory system (foam under the feet and vibration system). In addition, this study will evaluate balance in double task situations and dynamic stability. Given the consequent impact of chemotherapy and peripheral neuropathies on quality of life, a quality of life questionnaire will also be administered. ;

Related Conditions & MeSH terms

• Breast Neoplasms
• Cancer, Breast
• Cancer, Gynecologic

• NCT number: NCT04692168
• Study type: Observational
• Source: School of Health Sciences Geneva
• Status: Completed
• Start date: October 7, 2020
• Completion date: December 31, 2022